Updated Jul 16, 2026
Ben Arye Barak has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Arye Barak Ben serves as the General Counsel for NovoCure Ltd, a company specializing in oncology treatments using Tumor Treating Fields technology. His role involves overseeing legal matters and compliance within the organization.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | NVCR | NovoCure Ltd | A — Grant or award | 1.3K | $11.15 | $14K |
| 2026-03-05 | NVCR | NovoCure Ltd | A — Grant or award | 50.1K | $0.00 | |
| 2026-03-03 | NVCR | NovoCure Ltd | A — Grant or award | 17.8K | $0.00 | |
| 2025-06-30 | NVCR | NovoCure Ltd | A — Grant or award | 769 | $15.13 | $12K |
Arye Barak Ben serves as the General Counsel for NovoCure Ltd, a company specializing in oncology treatments using Tumor Treating Fields technology. His role involves overseeing legal matters and compliance within the organization.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ben Arye Barak profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.